title: Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.
authors.affiliation: Department of Surgery/Urology, University of Toronto, Toronto, Ontario, Canada. s.herschorn@utoronto.ca
authors.forename: Sender
authors.initials: S
authors.lastname: Herschorn
authors.forename: Lynn
authors.initials: L
authors.lastname: Stothers
authors.forename: Kevin
authors.initials: K
authors.lastname: Carlson
authors.forename: Blair
authors.initials: B
authors.lastname: Egerdie
authors.forename: Jerzy B
authors.initials: JB
authors.lastname: Gajewski
authors.forename: Peter
authors.initials: P
authors.lastname: Pommerville
authors.forename: Jane
authors.initials: J
authors.lastname: Schulz
authors.forename: Sidney
authors.initials: S
authors.lastname: Radomski
authors.forename: Harold
authors.initials: H
authors.lastname: Drutz
authors.forename: Jack
authors.initials: J
authors.lastname: Barkin
authors.forename: Fran
authors.initials: F
authors.lastname: Paradiso-Hardy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002170:Canada / Q000453:epidemiology; D016009:Chi-Square Distribution; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011812:Quinuclidines / Q000008:administration & dosage*; D012720:Severity of Illness Index; D000069464:Solifenacin Succinate; D011795:Surveys and Questionnaires; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage*; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014987:Xerostomia / Q000139:chemically induced / Q000453:epidemiology
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; C005419:oxybutynin; D000069464:Solifenacin Succinate